Tiziana Life Sciences
(NASDAQ) TLSA
Tiziana Life Sciences Financials at a Glance
Market Cap
$175.90M
Revenue (TTM)
$0.00
Net Income (TTM)
$34.95M
EPS (TTM)
$-0.16
P/E Ratio
-9.50
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$1.49
Volume
11,299
Open
$1.51
Price
$1.49
Volume
11,299
Open
$1.51
Previous Close
$1.49
Daily Range
$1.41 - $1.56
52-Week Range
$1.14 - $2.60
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$1.49
Volume
11,299
Open
$1.51
Previous Close
$1.49
Daily Range
$1.41 - $1.56
52-Week Range
$1.14 - $2.60
TLSA News
TLSA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tiziana Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
Ivor Elrifi, PhD
Website
www.tizianalifesciences.comHeadquarters
London, W1K 1NA, GB
TLSA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-924%
Return on Capital
-45%
Return on Assets
-37%
Earnings Yield
-10.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$175.90M
Shares Outstanding
118.85M
Volume
11.30K
Avg. Volume
177.39K
Financials (TTM)
Gross Profit
$234.00K
Operating Income
$21.28M
EBITDA
$21.05M
Operating Cash Flow
$12.85M
Capital Expenditure
$21.00K
Free Cash Flow
$12.87M
Cash & ST Invst.
$4.01M
Total Debt
$456.00K
Tiziana Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$146.00K
-256.1%
Gross Margin
0.00%
N/A
Market Cap
$175.90M
N/A
Market Cap/Employee
$19.54M
N/A
Employees
9
N/A
Net Income
$12.80M
-41.1%
EBITDA
$12.18M
-42.0%
Quarterly Fundamentals
Net Cash
$3.55M
+279.7%
Accounts Receivable
$4.26M
-29.7%
Inventory
$0.00
N/A
Long Term Debt
$234.00K
+114.7%
Short Term Debt
$222.00K
-19.6%
Return on Assets
-36.98%
N/A
Return on Invested Capital
-44.82%
N/A
Free Cash Flow
$6.04M
-77.2%
Operating Cash Flow
$6.02M
-76.8%